Description
Added on the 16/03/2021 16:29:02 - Copyright : France 24 EN
The EU's drug regulator says it remains "firmly convinced" of the benefits of AstraZeneca's coronavirus vaccine despite several countries suspending its use over blood clot fears. SOUNDBITE
The European Medicines Agency is the EU regulatory body responsible for COVID-19 vaccine approval. Now, Gizmodo reports a cyberattack on EMA's servers has produced an 'unlawful access' of documents related to a potential COVID-19 vaccine. The EMA’s own statement on the attacks doesn’t disclose much, but does confirm that the breach happened. However, pharma giant Pfizer and its German partner, BioNTech, announced that some of their own documents were caught up in the breach. There’s a chance that this latest attack might push Pfizer/BioNTech's timeline for an EU regulatory review of its proposed vaccine back a bit.
Inondations : Nîmes sauvée des eaux
The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits increase with age, despite links to blood clots. SOUNDBITE
The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits still outweigh the risks for adults despite links to blood clots. SOUNDBITE
Europe's medicines regulator says that blood clots should be listed as a very rare side effect of Johnson & Johnson's coronavirus vaccine, but that the benefits of the shot still outweigh the risks. SOUNDBITE
|
Support : Technical 
- Content 
- Editors 
